Saltar al contenido
Merck
Todas las fotos(2)

Documentos clave

Ver Toda la documentación

HT110216

Sigma-Aldrich

Eosin Y Solution, Aqueous

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(2)

About This Item

UNSPSC Code:
41116124
NACRES:
NA.47

form

solution

Quality Level

500

shelf life

Expiry date on the label.

IVD

for in vitro diagnostic use

concentration

0.5 % (w/v) in water

application(s)

hematology
histology

storage temp.

room temp

¿Está buscando productos similares? Visita Guía de comparación de productos

Application

General purpose cytoplasmic counterstain. Used with hematoxylin and eosin staining.

Other Notes

Certified Eosin Y, 0.5% (w/v) in water. Not acidified.

Storage Class

10 - Combustible liquids

wgk_germany

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)

Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number
0000328578
0000288372
0000328578
SLCR5130
SLCN7192

¿No ve la versión correcta?

Si necesita una versión concreta, puede buscar un certificado específico por el número de lote.

Busque por un COA

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Senna Staessens et al.
Haematologica, 105(2), 498-507 (2019-05-03)
Ischemic stroke is caused by a thromboembolic occlusion of cerebral arteries. Treatment is focused on fast and efficient removal of the occluding thrombus, either via intravenous thrombolysis or via endovascular thrombectomy. Recanalization, however, is not always successful and factors contributing
Frederik Denorme et al.
Blood, 127(19), 2337-2345 (2016-03-02)
Rapid vascular recanalization forms the basis for successful treatment of cerebral ischemia. Currently, tissue plasminogen activator (t-PA) is the only approved thrombolytic drug for ischemic stroke. However, t-PA does not always result in efficient thrombus dissolution and subsequent blood vessel
Kenneth C Valkenburg et al.
Oncotarget, 8(46), 80265-80277 (2017-11-09)
Prostate cancer is the most diagnosed non-skin cancer in the US and kills approximately 27,000 men per year in the US. Additional genetic mouse models are needed that recapitulate the heterogeneous nature of human prostate cancer. The Wnt/beta-catenin signaling pathway
Vincent W Yang et al.
Molecular cancer research : MCR, 17(1), 165-176 (2018-08-16)
Krüppel-like factor 4 (KLF4), a zinc finger transcription factor, regulates homeostasis of the intestinal epithelium. Previously, it was reported that KLF4 functions as a tumor suppressor in colorectal cancer. Here, evidence demonstrates that KLF4 mitigates the development and progression of
Kenneth C Valkenburg et al.
The Prostate, 74(15), 1506-1520 (2014-09-02)
Wnt/β-catenin signaling is important for prostate development and cancer in humans. Activation of this pathway in differentiated luminal cells of mice induces high-grade prostate intraepithelial neoplasia (HGPIN). Though the cell of origin of prostate cancer has yet to be conclusively
Ver todos los artículos relacionados

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico